Authors: Lotfi, K Mansson, E Chandra, J Wang, YY Xu, DW Knaust, E Spasokoukotskaja, T Liliemark, E Eriksson, S Albertioni, F

Citation: K. Lotfi et al., Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide, BR J HAEM, 113(2), 2001, pp. 339-346

Authors: Csapo, Z Sasvari-Szekely, M Spasokoukotskaja, T Talianidis, I Eriksson, S Staub, M

Citation: Z. Csapo et al., Activation of deoxycytidine kinase by inhibition of DNA synthesis in humanlymphocytes, BIOCH PHARM, 61(2), 2001, pp. 191-197

Authors: Csapo, Z Sasvari-Szekely, M Spasokoukotskaja, T Staub, M

Citation: Z. Csapo et al., Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF, ACT BIOCH P, 48(1), 2001, pp. 251-256

Authors: Lotfi, K Mansson, E Spasokoukotskaja, T Pettersson, B Liliemark, J Peterson, C Eriksson, S Albertioni, F

Citation: K. Lotfi et al., Biochemical pharmacology and resistance to 2-chloro-2 '-arabinonuoro-2 '-deoxyadenosine, a novel analogue of cladribine in human leukemic cells, CLIN CANC R, 5(9), 1999, pp. 2438-2444

Authors: Spasokoukotskaja, T Sasvari-Szekely, M Keszler, G Albertioni, F Eriksson, S Staub, M

Citation: T. Spasokoukotskaja et al., Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity, EUR J CANC, 35(13), 1999, pp. 1862-1867

Authors: Mansson, E Spasokoukotskaja, T Sallstrom, J Eriksson, S Albertioni, F

Citation: E. Mansson et al., Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line, CANCER RES, 59(23), 1999, pp. 5956-5963